Khani M Hosseinali, Smedh K, Kraaz W
Colorectal Unit, Department of Surgery, Central Hospital, Västerås and Centre for Clinical Research, Uppsala University, Uppsala, Sweden.
Colorectal Dis. 2007 Oct;9(8):706-12. doi: 10.1111/j.1463-1318.2007.01263.x. Epub 2007 May 29.
Circumferential resection margin (CRM) involvement has been correlated with a high risk of developing local recurrence. The aim of this study was to examine the prognostic significance of the CRM involvement after curative resection of rectal cancer in patients treated with preoperative radiotherapy and postoperative chemotherapy where indicated.
All patients with rectal cancer treated in a regional central unit from 1996 to 2004 were identified. A surgical resection was performed on 257 patients, and in 229 of these this was assessed as potentially curative. The CRM was examined in all patients. A CRM of < or = 1 mm was considered positive.
A positive margin was seen in 19 (8%) patients. At a median follow up of 40 months, only four (1.7%) patients had developed local recurrence, one of whom had a positive CRM. In the four patients the tumour was 5 cm or less from the anal verge. There were no significant differences regarding local recurrence and survival between CRM positive and negative tumours.
Rectal cancer managed by combined radiochemotherapy and surgery resulted in a low positive CRM rate and a low local recurrence rate. An involved CRM was not a predictor of local recurrence.
环周切缘(CRM)受累与局部复发的高风险相关。本研究的目的是探讨在术前放疗及必要时术后化疗的患者中,直肠癌根治性切除术后CRM受累的预后意义。
确定1996年至2004年在区域中心单位接受治疗的所有直肠癌患者。对257例患者进行了手术切除,其中229例被评估为可能治愈性切除。对所有患者的CRM进行了检查。CRM≤1mm被视为阳性。
19例(8%)患者切缘阳性。在中位随访40个月时,仅4例(1.7%)患者发生局部复发,其中1例CRM阳性。这4例患者的肿瘤距肛缘5cm或更小。CRM阳性和阴性肿瘤之间在局部复发和生存方面无显著差异。
联合放化疗和手术治疗的直肠癌导致CRM阳性率低和局部复发率低。CRM受累不是局部复发的预测指标。